
Experts discover common leg problem suffered by millions can raise dementia risk by 25 per cent
Millions of people with varicose veins could have a significantly higher risk of memory robbing dementia, a Korean study has suggested.
Experts, who analysed data from almost half a million people, found those with the bulging, twisted veins were 23.5 per cent more likely to be diagnosed with dementia
The elevated risk held true after the scientists accounted for factors like age, sex, weight, smoking status and alcohol consumption—all known risk factors for the condition.
Men, current smokers and heavy drinkers with varicose veins were at especially high risk of developing dementia.
Writing in the journal PLOS One, the authors said the exact reasons why varicose veins might be related to dementia needed further study.
However, they suggested the link could lie with the fact the unsightly condition can indicate poor blood flow around the body, which is a known risk factor for dementia.
Another theory is that varicose veins may be contributing to broad inflammation in the body, helping drive or exacerbate processes that cause brain damage.
The study also found that patients who had their veins treated were 43 per cent less likely than those who didn't undergo treatment to suffer from vascular dementia—the type specifically caused by a series of mini strokes that limit blood flow to the brain.
The researchers analysed health data from 396,767 men and women in Korea with an average age of 56, of which about 5,000 had varicose veins.
Participants' health records were tracked for an average of 13 years. By the end of this period, 14 per cent had been diagnosed with dementia.
While a large study the authors noted their research had several limitations.
Firstly, it was observational, meaning that while the data suggested a link between varicose veins and dementia it cannot prove one condition causes the other.
Secondly, the data the scientists used only recorded the presence of varicose veins among patients, not the severity of the condition.
The authors suggested assessing if patients with worse veins have a greater risk of dementia is an area in need of further study.
Additionally, experts were unable to account for genetic predisposition to the condition, which may have influenced the results.
Finally, they noted their study involved a group of Korean patients and therefore might have limited application to other populations.
An estimated one in four men and one in three women in the UK are thought to have varicose veins.
In the US, approximately 11million men and 22million women are living with the condition.
Varicose veins are widened blood vessels that look swollen and twisted close to the surface of the skin and in some cases may bulge out in lumps.
They can cause pain, skin problems and swollen limbs and extremities.
While most common on the legs they can also occur in other areas of the body.
Risk factors for varicose veins include sitting or standing for long periods, as well as smoking and being overweight.
While the odds of getting varicose veins broadly increase with age, some groups, like pregnant women, are at increased risk.
Approximately two in every five expectant mothers—just under half—will get varicose veins during their pregnancy.
While not considered a serious medical problem those who are experiencing significant pain or complications can be offered treatment.
This can include minor procedures to either remove the veins or restrict blood flow, or compression stockings. Dementia affects an estimated one million people in the UK.
Recent analysis by the Alzheimer's Society estimated the overall annual cost of the dementia to the UK is £42billion a year, with families bearing the brunt.
An ageing population means these costs—which include lost earnings of unpaid carers—are set to soar to £90billion in the next 15 years.
A separate Alzheimer's Research UK analysis found 74,261 people died from dementia in 2022 compared with 69,178 a year earlier, making it the country's biggest killer.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
8 minutes ago
- BBC News
TB: India brought forward its tuberculosis elimination deadline - but can it meet it?
Atul Kumar (name changed) anxiously paced the corridor of a public hospital in India's capital Delhi.A small-appliance mechanic, he was struggling to secure medicines for his 26-year-old daughter who suffers from drug-resistant tuberculosis (TB). Mr Kumar said his daughter needed 22 tablets of Monopas, an antibiotic used for treating TB, every day. "In the past 18 months, I haven't received government-supplied medicine for even two full months," he told BBC Hindi in January, months before India's declared deadline to eliminate the infectious to buy costly drugs from private pharmacies, Mr Kumar was drowning in debt. A week's supply cost 1,400 rupees ($16; £12), more than half his weekly income. After the BBC raised the issue, authorities supplied the medicines Mr Kumar's daughter needed. Federal Health Secretary Punya Salila Srivastava said that the government usually acts quickly to fix medicine access issues when Kumar's daughter is one of millions of Indians suffering from tuberculosis, a bacterial disease that infects the lungs and is spread when the infected person coughs or home to 27% of the world's tuberculosis cases, sees two TB-related deaths every three minutes. India's TB burden has long been tied to poor case detection, underfunding and erratic drug this grim reality, the country has set an ambitious goal. It aims to eliminate TB by the end of 2025, five years ahead of the global target set by the World Health Organization (WHO) and United Nations member as defined by the WHO, means cutting new TB cases by 80% and deaths by 90% compared with 2015 visits to TB centres in Delhi and the eastern state of Odisha revealed troubling gaps in the government's TB Odisha's Khordha district, around 30km (18.6 miles) from state capital Bhubaneshwar, 32-year-old day-labourer Kanhucharan Sahu is struggling to continue his two-year-old daughter's TB treatment, with government medicines unavailable for three months and private ones costing 1,500 rupees a month - an unbearable burden."We can't see her suffer anymore," he says, his voice breaking. "We even thought of abandoning her."At Odisha's local TB office, officials promised to review Sahu's case, but a staffer admitted, "We rarely get the medicines we need, so we ration them." Mr Sahu says he hasn't received the promised 1,000 rupees monthly support from the federal government and at the local TB office, officials admit to chronic shortages, leaving families like his adrift in a failing Routray, who runs the patient support group Sahyog, says medicine shortages are now routine, with government outlets often running dry. "How can we talk about ending TB with such gaps?" she are other hurdles too - for example, changing treatment centres involves navigating complex bureaucracy, a barrier that often leads to missed doses and incomplete care. This poses a major hurdle for India's vast population of migrant a hospital near Khordha, 50-year-old Babu Nayak, a sweeper who was diagnosed with TB in 2023, struggles to continue his treatment. He was regularly forced to travel 100km to his village for medicines as officials insisted he collect them from the original centre where he was diagnosed and first treated. "It became too difficult," he to travel so often, Mr Nayak stopped taking the medication altogether."It was a mistake," he admitted, after contracting TB again last year and being his hospital, no TB specialist was available, highlighting another critical gap in India's fight: a shortage of frontline health BBC shared its findings with the federal health ministry and officials in charge of the TB programme in Delhi and Odisha. There was no response despite repeated reminders.A 2023 parliamentary report showed there were many vacant roles across all levels of the TB programme, affecting diagnosis, treatment and follow-up - especially in rural and underserved vaccines help India triumph over tuberculosis?In 2018, when Prime Minister Narendra Modi brought forward India's TB elimination target to 2025, he cited the government's intensified efforts as a reason for optimism. Two years later, the Covid pandemic disrupted TB elimination efforts globally, delaying diagnosis, diverting resources and pausing routine services. Medicine shortages, staff constraints and weakened patient monitoring have further widened the gap between ambition and these challenges, India has made some the past decade, the country has reduced its tuberculosis-related mortality. Between 2015 and 2023, TB deaths declined from 28 to 22 per 100,000 people. This figure, however, is still high when compared with the global average which stands at number of reported cases has gone up, which the government credits to its targeted outreach and screening programmes. In 2024, India recorded 2.6 million TB cases, up from 2.5 million in 2023. Federal Health Minister JP Nadda recently touted innovations like handheld X-ray devices as game-changers in expanding testing. But on the ground, the picture is less optimistic."I still see some patients come to me with reports of sputum (phlegm) smear microscopy for TB, a test which has a much lower detection rate as compared to genetic tests," says Dr Lancelot Pinto, a Mumbai-based tests, which includes RT-PCR machines - widely used to diagnose HIV, influenza and most recently, Covid-19 - and Nucleic Acid Amplification Testing, also examine the sputum sample but with greater sensitivity and in a shorter the tests can reveal whether the TB strain is drug-resistant or sensitive, something that microscopic testing can't do, Dr Pinto gap, he adds, stems not just from lack of awareness but from limited access to modern tests."Genetic testing is free at government hospitals but not uniformly available, with only a few states being able to provide it."In May, Modi led a high-level review of India's TB elimination programme, reaffirming the country's commitment to defeating the the official statement notably skipped mention of the 2025 deadline. Instead, it highlighted community-driven strategies - better sanitation, nutrition and social support for TB-affected families - as key to the government has also prioritised better diagnosis, treatment and prevention at the core of its elimination approach mirrors the WHO's view of TB as a "disease of poverty". In its 2024 report, WHO chief Tedros Adhanom Ghebreyesus called it "the definitive disease of deprivation", noting how poverty, malnutrition and treatment costs trap patients in a vicious cycle. As India pushes toward its goal of eliminating the disease, deep health and social inequalities remain just six months left until India's self-imposed deadline, new complications have fallout from US President Donald Trump's withdrawal from the WHO and suspension of USAID operations has raised concerns about future funding for global TB efforts. Since 1998, USAID has invested more than $140m to help diagnose and treat TB patients in India. However, India's federal health secretary insists there is "no budgetary problem" hope lies on the horizon. Sixteen TB vaccine candidates are currently in development across the world, with the WHO projecting potential availability within five years, pending successful trials.


The Independent
8 hours ago
- The Independent
Rare cancer with nonspecific symptoms increasing among millennials
A study published in Annals of Internal Medicine indicates a surprising increase in appendix cancer rates among Millennials and Generation X, suggesting a higher disease burden in younger generations. The study assessed data from 4,858 patients diagnosed with appendix cancer between 1975 and 2019, categorising them into five-year age groups to understand how the risk evolved over the years. Compared to the 1945 birth cohort, the incidence of appendix cancer more than tripled in individuals born around 1980 and quadrupled by the birth cohort of 1985. Researchers suggest that environmental, lifestyle, and genetic factors intensified after World War II, such as dietary patterns, gut bacteria alterations, and gastrointestinal inflammation, may explain the increase. The study calls for more research, particularly involving genomics data, to uncover the mechanisms driving this trend and urges physicians to revisit screening protocols and develop early detection biomarkers.


The Independent
11 hours ago
- The Independent
Older millennials are increasingly getting this rare cancer type
Doctors are reporting a surprising increase in appendix cancer rates among millennials and Generation X, indicating that a higher disease burden may affect younger generations. Appendiceal adenocarcinoma is a rare form of appendix cancer which sees a malignant tumour originate in the appendix's lining and secrete a mucus-like substance. The appendix is a small tubular organ in the gut historically considered vestigial in humans. It harbours glandular tissues that are known to be susceptible to becoming cancerous. This type of cancer is often diagnosed incidentally or at advanced stages because of nonspecific symptoms like abdominal pain, bloating, and changes in bowel habits. Researchers say people born after 1945 in the US, particularly G X and millennials, are experiencing a significant increase in cases of appendiceal adenocarcinoma, indicating a concerning and previously unrecognised trend. A study published recently in Annals of Internal Medicine assessed the incidence of appendix cancer from 1975 to 2019 among people born in various time periods after the second world war to understand how its risk evolved over the years. They assessed data from 4,858 patients, aged 20 years or older, diagnosed with appendix cancer. The patients were categorised into five-year age groups to create 21 overlapping birth categories. Their tumours varied, with types in which the cell mass produced mucous and those in which the cancer cells did not shed mucous as well as other subtypes. The researchers found that compared to the 1945 birth cohort, the cancer incidence more than tripled in individuals born around 1980 and 'astonishingly quadrupled' by the birth cohort of 1985. The magnitude of rise also appeared to vary among the cancer subtypes. The researchers suggest that environmental, lifestyle and genetic factors that intensified after the second world war may explain the concerning increase in appendix cancer rates. They point to dietary patterns, gut bacteria alterations, greater prevalence of conditions inflaming the gastrointestinal tract in particular. 'Similar trends have been reported for other gastrointestinal cancers, suggestive of potential shared cause contributing to this increasing cancer burden across generations,' the study noted. It calls for more research to unravel these associations, particularly involving genomics data to uncover mechanisms driving the alarming trend. They also urge physicians to revisit screening protocols and develop early detection biomarkers to facilitate timely diagnosis and treatment.